文献速递脑血管病认知障碍与痴呆

2型糖尿病与肾功能受损和卒中后脑结构改变及认知下降相关

Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline.
PubMed 文献 · Stroke · 2017-08-11

TABASCO前瞻性队列纳入卒中/TIA幸存者,基线用3-T MRI测量脑与海马体积及白质完整性,507例在24个月时评估认知。结果显示T2DM和eCCl<60 mL/min均与脑萎缩及认知下降独立相关,二者并存时认知下降风险近乎翻倍于单一异常、近四倍于无异常者。

要点

  • T2DM与eCCl<60 mL/min均独立关联卒中后脑萎缩和认知下降
  • 两者并存时认知下降风险约为无异常者的四倍
  • 卒中后评估肾功能与血糖有助于识别认知下降高危患者

核心结论

  • T2DM和肾功能受损独立关联卒中后脑结构异常及认知测试表现更差。
  • T2DM与eCCl<60 mL/min对脑萎缩和认知下降风险有独立且叠加的作用。

研究设计与样本

  • TABASCO为卒中/短暂性脑缺血发作幸存者的前瞻性队列研究。
  • 基线用3-T MRI测量脑与海马体积、白质完整性及缺血病灶。
  • 507例患者在24个月时接受认知测试并诊断为轻度认知障碍、痴呆或认知完好。

主要发现

  • 基线时T2DM和eCCl<60 mL/min与更小的脑和海马体积、皮层厚度减低及白质微观结构完整性更差相关。
  • 两年后T2DM和eCCl<60 mL/min均与更差的认知评分相关,19.7%的参与者出现认知下降(轻度认知障碍或痴呆)。
  • 控制年龄、性别、教育程度和载脂蛋白E4后,T2DM和eCCl<60 mL/min均与认知下降显著相关。
  • 同时具备两种状况者认知下降风险为仅有T2DM或eCCl<60 mL/min者的两倍,为无任一异常者的近四倍。

临床怎么用

  • 对卒中/TIA幸存者应关注T2DM与肾功能(eCCl<60 mL/min)以评估认知下降风险。
  • 两者并存提示脑萎缩和认知下降风险更高,可据此加强随访与认知监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Type 2 diabetes mellitus (T2DM) is associated with diseases of the brain, kidney, and vasculature. However, the relationship between T2DM, chronic kidney disease, brain alterations, and cognitive function after stroke is unknown. We aimed to evaluate the inter-relationship between T2DM, impaired renal function, brain pathology on imaging, and cognitive decline in a longitudinal poststroke cohort. METHODS: The TABASCO (Tel Aviv brain acute stroke cohort) is a prospective cohort of stroke/transient ischemic attack survivors. The volume and white matter integrity, ischemic lesions, and brain and hippocampal volumes were measured at baseline using 3-T MRI. Cognitive tests were performed on 507 patients, who were diagnosed as having mild cognitive impairment, dementia, or being cognitively intact after 24 months. RESULTS: At baseline, T2DM and impaired renal function (estimated creatinine clearance [eCCl] <60 mL/min) were associated with smaller brain and hippocampal volumes, reduced cortical thickness, and worse white matter microstructural integrity. Two years later, both T2DM and eCCl <60 mL/min were associated with poorer cognitive scores, and 19.7% of the participants developed cognitive decline (mild cognitive impairment or dementia). Multiple analysis, controlling for age, sex, education, and apolipoprotein E4, showed a significant association of both T2DM and eCCl <60 mL/min with cognitive decline. Having both conditions doubled the risk compared with patients with T2DM or eCCl <60 mL/min alone and almost quadrupled the risk compared with patients without either abnormality. CONCLUSIONS: T2DM and impaired renal function are independently associated with abnormal brain structure, as well as poorer performance in cognitive tests, 2 years after stroke. The presence of both conditions quadruples the risk for cognitive decline. T2DM and lower eCCl have an independent and additive effect on brain atrophy and the risk of cognitive decline. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01926691.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Ben Assayag E, Eldor R, Korczyn AD, et al. Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline. Stroke. 2017. PMID: 28801477. doi:10.1161/STROKEAHA.117.017709

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。